Department of Pediatrics, CHU Limoges, Limoges, France; Division of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Jeanne de Flandre Children's Hospital, CHU Lille and University Lille, Lille, France.
Division of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Jeanne de Flandre Children's Hospital, CHU Lille and University Lille, Lille, France; University Lille, Inserm, CHU Lille, U1286 - INFINITE - Institute for Translational Research in Inflammation, Lille, France.
J Pediatr. 2022 Dec;251:134-139.e2. doi: 10.1016/j.jpeds.2022.07.010. Epub 2022 Jul 16.
To compare the efficacy of, and complications from, the 2 main treatments for achalasia: endoscopic dilatation and surgical cardiomyotomy (Heller's myotomy).
We retrospectively collected data on children treated for achalasia over an 11-year period from 8 tertiary pediatric centers. A line of treatment was defined as performing either Heller's myotomy or 1-3 sessions of endoscopy dilatation over 3 months. Treatment success was a priori defined as clinical improvement and no need for new treatment.
Ninety-seven children (median age, 12 years; 57% boys) were included. The median time to diagnosis was 10.5 months, and the median follow-up period was 27 months. Thirty-seven children were treated by Heller's myotomy and 60 by endoscopy dilatation as the first-line treatment. After adjustment for potentially confounding factors, Heller's myotomy was significantly more successful than endoscopy dilatation (hazard ratio, 3.93 [1.74; 8.88]; P = .001), with a median survival without failure of 49 and 7 months, respectively, and with no significant difference in the occurrence of complications (35.2% for Heller's myotomy, 29.7% for endoscopy dilatation, P = .56). Hydrostatic dilatation was as successful as pneumatic dilatation (hazard ratio, 1.35 [0.56; 3.23]; P = .50).
Heller's myotomy is more successful than endoscopy dilatation, with no significant difference in the occurrence of serious complications. This raises the potential role of peroral endoscopic myotomy as an alternative treatment to Heller's myotomy.
比较治疗贲门失弛缓症的两种主要方法——内镜扩张和外科肌切开术(Heller 肌切开术)的疗效和并发症。
我们回顾性地收集了 8 家三级儿科中心在 11 年内治疗贲门失弛缓症的儿童数据。一种治疗方案被定义为在 3 个月内进行 Heller 肌切开术或 1-3 次内镜扩张。治疗成功是预先定义的,即临床改善且无需新的治疗。
97 名儿童(中位数年龄为 12 岁;57%为男孩)纳入研究。诊断中位时间为 10.5 个月,中位随访时间为 27 个月。37 名儿童接受 Heller 肌切开术治疗,60 名儿童接受内镜扩张作为一线治疗。在调整潜在混杂因素后,Heller 肌切开术明显比内镜扩张更成功(风险比为 3.93 [1.74;8.88];P=0.001),无失败中位生存时间分别为 49 个月和 7 个月,且并发症发生率无显著差异(Heller 肌切开术为 35.2%,内镜扩张为 29.7%,P=0.56)。水压扩张与气压扩张同样成功(风险比为 1.35 [0.56;3.23];P=0.50)。
Heller 肌切开术比内镜扩张更成功,且严重并发症的发生率无显著差异。这提示经口内镜肌切开术可能成为 Heller 肌切开术的替代治疗方法。